Qualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity Requirement
December 05, 2024 09:00 ET
|
Qualigen Therapeutics, Inc.
Carlsbad, CA, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics (NASDAQ: QLGN) (the “Company” or “Qualigen”) today announced that the Company received formal notice from The Nasdaq Stock...
Baosheng Media Group Holdings Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement
April 07, 2023 08:00 ET
|
Baosheng Media Group Holdings Limited
Beijing, China, April 07, 2023 (GLOBE NEWSWIRE) -- Baosheng Media Group Holdings Limited (NASDAQ: BAOS) (“Baosheng” or the “Company”), a China-based online marketing solution provider, today...
TOUGHBUILT™ REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT.
April 29, 2020 11:07 ET
|
Toughbuilt Industries, Inc
LAKE FOREST, Calif, April 29, 2020 (GLOBE NEWSWIRE) -- ToughBuilt Industries, Inc. (“ToughBuilt” or “Company”) (NASDAQ: TBLT; TBLTW) is an advanced product design, manufacturer and distributor with...
Akers Biosciences Granted 180-Day Extension by Nasdaq to Meet Minimum Bid Price Requirement
May 30, 2018 18:09 ET
|
Akers Biosciences Inc
THOROFARE, N.J., May 30, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces...